Our Scientific Advisory Board
Our Scientific Advisory Board (SAB) brings together eminent neuroblastoma scientists and clinicians. A new Board is selected for each major research grant round, after we have received all research grant applications.
We make a conscious effort to find Board members who are totally independent of any applications and have the relevant breadth of knowledge and experience to effectively peer review the science which has been presented to us.
The SAB play a key role in our grant research funding process, recommending applications and providing counsel to our Board of Trustees.
The Scientific Advisory Board 2024:
Dr Meredith Irwin is a Professor of Paediatrics and Clinician-scientist focused on translational neuroblastoma research at the Hospital for Sick Children (Sick Kids) and University of Toronto.
Prof Heinrich Kovar has been Head of the Molecular Biology of Solid tumours group at St Anna’s Cancer Research Institute, Vienna since 1988 and was scientific director of the Institute from 2001 to 2017.
Dr Julia Glade Bender is Vice Chairman for Clinical Research in the Department of Pediatrics at Memorial Sloan Kettering Cancer Center (MSK Kids), New York.
Dr Kelly Goldsmith is Professor of Paediatrics at Emory University School of Medicine, Atlanta and Curing Kids Cancer Endowed Chair of Paediatric Oncology.
Prof Kaat Durinck , is an Assistant professor at the Paediatric Precision Oncology Lab at Ghent University, Belgium.
Prof Heike Laman graduated from the University of Miami with her Bachelor of Science and her PhD in Microbiology and Immunology from Columbia University in New York.